Ironwood Pharmaceuticals IRWD
NASDAQ IRWD
$4.11 -0.25 (-5.62%)
At close: Aug 20, 2026 · 3:07 PM UTC

Ironwood Pharmaceuticals (IRWD) Return on Invested Capital (2021 - 2026)

Ironwood Pharmaceuticals (IRWD) posted Return on Invested Capital of 0.02% for Q1 2026, down 651.34% sequentially from 0.0% in Q4 2025.

Ironwood Pharmaceuticals (IRWD) Return on Invested Capital (2021 - 2026) Analysis & Trends

Ironwood Pharmaceuticals has reported Return on Invested Capital for 6 years, with the latest figure at 0.02% in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Haleon 43.86 Bn 42.90 Bn - -
2 Teva Pharmaceutical Industries 43.19 Bn 39.54 Bn 2.15 Bn 0.00%
3 Zoetis 31.46 Bn 29.79 Bn 1.05 Bn -
4 Takeda Pharmaceutical 28.57 Bn 22.77 Bn 5.10 Bn 0.00%
5 United Therapeutics 22.15 Bn 19.49 Bn 683.80 Mn -
6 Viatris 18.75 Bn 17.86 Bn 1.46 Bn 0.00%
7 Neurocrine Biosciences 15.50 Bn 15.11 Bn 935.80 Mn -
8 Elanco Animal Health 11.71 Bn 11.18 Bn 798.00 Mn 0.03%
9 Dr Reddys Laboratories 10.12 Bn 9.95 Bn - -
10 Ironwood Pharmaceuticals 676.53 Mn 597.40 Mn - 0.00%

Historic Data

Download Data
DateValue
Jun 30, 2026 0.00%
Mar 31, 2026 -0.02%
Dec 31, 2025 0.00%
Sep 30, 2025 0.00%
Dec 31, 2024 0.00%
Sep 30, 2024 0.00%
Jun 30, 2024 0.00%
Mar 31, 2024 -0.01%
Dec 31, 2023 -0.02%
Sep 30, 2023 -0.03%
Dec 31, 2022 0.01%
Sep 30, 2022 0.01%
Jun 30, 2022 0.00%
Mar 31, 2022 0.01%
Dec 31, 2021 0.02%
Sep 30, 2021 0.04%